Dr. Arunkanth Krishnakumar

Zeus Hygia Lifesciences announced a randomized, double‑blind, placebo‑controlled crossover trial of Metaberine® 200 mg daily in 36 adults at metabolic risk. The study reported a 9.08 mg/dL reduction i